Close
Digital Health & Ai Innovation summit 2026
APE 2026

Boston Scientific to Participate in Jefferies 2016 Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Natera Adds ctDNA-Based MRD Tests with...

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from...

The federal government has formally withdrawn the Biden-era minimum...
Boston Scientific Corporation   is scheduled to participate in the Jefferies 2016 Healthcare Conference on June 7, in New York City.
Susie Lisa, vice president, Investor Relations, will participate in a 25-minute presentation with the host analyst beginning at approximately 9:00 a.m. ET.  Following a 5-minute break, a question-and-answer session with audience members will begin at approximately 9:30 a.m. ET.
 
A live webcast of the presentation and question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visitwww.bostonscientific.com .
 
CONTACTS
Media:    
Tom Keppeler    
508-683-6585 (office)      
Media Relations    
Boston Scientific Corporation    
thomas.keppeler@bsci.com   
investor_relations@bsci.com
Investors:
Susie Lisa, CFA
508- 683-5565 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com

Latest stories

Related stories

Natera Adds ctDNA-Based MRD Tests with Acquisition of Foresight Diagnostics

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from Minimum Nurse Staffing Rule Repeal

The federal government has formally withdrawn the Biden-era minimum...

Purehealth, Dorchester Partner to Bring Luxury Hospitality in Healthcare

PureHealth has gone on to announce a first-of-its-kind partnership...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »